Nina Bhardwaj, MD/PhD

Icahn School of Medicine at Mount Sinai

Nina Bhardwaj, MD, PhD, holds the Ward-Coleman Chair in Cancer Research and is a Professor of Medicine, Hematology and Oncology at the Icahn School of Medicine at Mount Sinai. Dr. Bhardwaj, Director of Immunotherapy at The Tisch Cancer Institute, is an immunologist who has made seminal contributions to human dendritic cell biology. She is also the founder and Medical Director of the Vaccine and Cell Therapy Lab at the Icahn School of Medicine at Mount Sinai, the first enterprise of its kind in the area.

Dr. Bhardwaj is an elected member of the American Society of Clinical Investigation and the American Association of Physicians, and a recipient of the Doris Duke Distinguished Scientist Award. In 2015, she received the Fred W. Alt Award for New Discoveries in Immunology from the Cancer Research Institute. She is a member of Mount Sinai’s institutional COVID Trials Oversight Committee, serving as the chair of the COVID Trials Vaccine Subcommittee, and as a member of 4 other subcommittees, owing to her expertise on dendritic cell and innate immunity research. Dr. Bhardwaj has also attracted multiple federal and foundation grants and has authored over 200 publications.

Riley Fadden, Apricity Health Advisor

Riley Fadden, MSN, FNP-BC